Illumina Inc (ILMN)
NASDAQ · Healthcare · Diagnostics & Research
Illumina Inc is a Healthcare company with a market capitalization of $28.51B and a trailing P/E ratio of 35.2.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $1.15 | $1.06 | +8.5% |
| Q4 2025 | February 5, 2026 | $1.35 | $1.23 | +9.8% |
| Q3 2025 | October 30, 2025 | $1.34 | $1.17 | +14.5% |
| Q2 2025 | July 31, 2025 | $1.19 | $1.01 | +17.8% |
| Q1 2025 | May 8, 2025 | $0.97 | $0.94 | +3.2% |
| Q4 2024 | February 6, 2025 | $0.86 | $0.92 | -6.5% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 8,752,414 | 5.68% | 4.4 | +15.7% |
| June 30, 2026 | 7,565,780 | 4.91% | 3.7 | -17.8% |
| June 15, 2026 | 9,207,473 | 5.98% | 4.5 | +19.2% |
| May 29, 2026 | 7,723,045 | 5.01% | 4.7 | +2.9% |
| May 15, 2026 | 7,503,141 | 4.87% | 4.0 | +14.6% |
| April 30, 2026 | 6,546,522 | 4.25% | 4.7 | -8.8% |
| April 15, 2026 | 7,178,290 | 4.66% | 5.2 | +3.2% |
| March 31, 2026 | 6,955,511 | 4.52% | 4.9 | -3.8% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Illumina Inc's market cap?
As of August 13, 2026, Illumina Inc (ILMN) has a market capitalization of $28.51B.
What is Illumina Inc's P/E ratio?
Illumina Inc trades at a trailing price-to-earnings (P/E) ratio of 35.2. Its forward P/E is 35.4.
Does Illumina Inc pay a dividend?
Illumina Inc does not currently pay a dividend.
What sector is ILMN in?
Illumina Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What is Illumina Inc's short interest?
As of the July 15, 2026 FINRA settlement, 8,752,414 ILMN shares were sold short, or 5.68% of shares outstanding. Days to cover: 4.4. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Illumina Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Illumina Inc reported revenue of $4.34B and net income of $850.00M.
Ask your own questions about ILMN
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.